JP2025513255A5 - - Google Patents
Info
- Publication number
- JP2025513255A5 JP2025513255A5 JP2024560859A JP2024560859A JP2025513255A5 JP 2025513255 A5 JP2025513255 A5 JP 2025513255A5 JP 2024560859 A JP2024560859 A JP 2024560859A JP 2024560859 A JP2024560859 A JP 2024560859A JP 2025513255 A5 JP2025513255 A5 JP 2025513255A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- kda
- hypothyroidism
- administered
- hpmc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22169513.3 | 2022-04-22 | ||
| EP22169513 | 2022-04-22 | ||
| EP22209460.9 | 2022-11-24 | ||
| EP22209460 | 2022-11-24 | ||
| PCT/EP2023/060373 WO2023203173A1 (en) | 2022-04-22 | 2023-04-20 | Compositions for modified release of active ingredients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513255A JP2025513255A (ja) | 2025-04-24 |
| JP2025513255A5 true JP2025513255A5 (https=) | 2026-04-20 |
Family
ID=86328542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560859A Pending JP2025513255A (ja) | 2022-04-22 | 2023-04-20 | 活性成分の改変放出のための組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250262160A1 (https=) |
| EP (1) | EP4511009A1 (https=) |
| JP (1) | JP2025513255A (https=) |
| KR (1) | KR20250002580A (https=) |
| CN (1) | CN119212685A (https=) |
| CA (1) | CA3249641A1 (https=) |
| IL (1) | IL316428A (https=) |
| MX (1) | MX2024012984A (https=) |
| WO (1) | WO2023203173A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6284262B1 (en) * | 1999-01-26 | 2001-09-04 | Virgil A. Place | Compact dosage unit for buccal administration of a pharmacologically active agent |
| AU2006230557A1 (en) * | 2005-03-31 | 2006-10-05 | King Pharmaceuticals Research & Development, Inc. | Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same |
| GB2462611A (en) * | 2008-08-12 | 2010-02-17 | Cambridge Lab | Pharmaceutical composition comprising tetrabenazine |
| US9526701B2 (en) | 2011-12-20 | 2016-12-27 | Keith R. Latham | Sustained drug release and improved product stability using non-covalent particle coating methods |
| EP4090313B1 (en) * | 2020-01-13 | 2024-03-13 | Amneal Complex Products Research LLC | Sustained release compositions comprising liothyronine |
-
2023
- 2023-04-20 JP JP2024560859A patent/JP2025513255A/ja active Pending
- 2023-04-20 US US18/858,476 patent/US20250262160A1/en active Pending
- 2023-04-20 IL IL316428A patent/IL316428A/en unknown
- 2023-04-20 EP EP23721363.2A patent/EP4511009A1/en active Pending
- 2023-04-20 CA CA3249641A patent/CA3249641A1/en active Pending
- 2023-04-20 WO PCT/EP2023/060373 patent/WO2023203173A1/en not_active Ceased
- 2023-04-20 KR KR1020247038545A patent/KR20250002580A/ko active Pending
- 2023-04-20 CN CN202380035252.5A patent/CN119212685A/zh active Pending
-
2024
- 2024-10-21 MX MX2024012984A patent/MX2024012984A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1245158C (zh) | 片剂组合物 | |
| CN109044981B (zh) | 一种普瑞巴林胃漂浮型缓释片及其制备方法 | |
| JP2021519288A5 (https=) | ||
| CN1525855A (zh) | 治疗与预防心脏病与循环系统疾病的日服一次疗法用口服的控释医药组合物 | |
| JP3633936B2 (ja) | センナ剤形 | |
| EP1462098B1 (en) | Stabilised pharmaceutical composition comprising a non-steroidal anti-inflammatory agent and a prostaglandin | |
| CN113908153A (zh) | 一种布瓦西坦药物组合物、其制备方法及应用 | |
| WO2019073477A1 (en) | PHARMACEUTICAL COMPOSITION OF APREMILAST WITH EXTENDED RELEASE | |
| JP6902043B2 (ja) | フマル酸ジメチルを含む医薬ビーズ製剤 | |
| EP4680203A1 (en) | Compositions for sustained release of poorly soluble active ingredients | |
| JP2017502062A5 (https=) | ||
| JP2025513255A5 (https=) | ||
| JP2007529564A5 (https=) | ||
| WO2003011256A1 (en) | Oral controlled release pharmaceutical composition of a prokinetic agent | |
| US20250312324A1 (en) | Prolonged-release oral solid formulation of pirfenidone | |
| RU2367438C2 (ru) | Матриксная таблетка с регулируемым высвобождением триметазидина | |
| EP2392318A1 (en) | A pharmaceutical controlled release composition of losartan | |
| JP2024503689A5 (https=) | ||
| JP2025535941A5 (https=) | ||
| MD4032530T2 (ro) | Compoziție de furazidină cu eliberare prelungită | |
| JP2010503689A5 (https=) | ||
| IL316428A (en) | Formulations for modified release of active ingredients | |
| RU2571067C2 (ru) | Хронотерапевтическая фармацевтическая композиция | |
| MXPA06010805A (es) | Formulacion de claritromicina de libracion prolongada. | |
| CN121971487A (en) | Pharmaceutical composition containing iron-acacia complex and preparation method thereof |